Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added to the Record History and the previous v3.5.3 entry was removed, indicating an updated revision state for the page.
    Difference
    0.1%
    Check dated 2026-05-15T15:59:47.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s interface revision/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a site release without changing the study record details shown.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:46.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Release notes updated to add Revision: v3.5.2 and remove Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:16:11.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T22:34:46.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.3 and removes the previous entry v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T19:57:45.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    A new site revision entry (v3.4.2) was added. The previous funding-lapse notice (v3.4.1) was removed.
    Difference
    0.7%
    Check dated 2026-02-11T04:40:09.000Z thumbnail image

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.